Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250853-13-000118
Filing Date
2013-11-27
Accepted
2013-11-27 19:42:59
Documents
1
Period of Report
2013-11-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4080
  Complete submission text file 0001250853-13-000118.txt   5758
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RXI PHARMACEUTICALS CORPORATION 60 PRESCOTT STREET WORCESTER MA 01605
Business Address
SCHWARTZ MARK W. (Reporting) CIK: 0001422882 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 131248907